1. Home
  2. VRAR vs IBIO Comparison

VRAR vs IBIO Comparison

Compare VRAR & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAR
  • IBIO
  • Stock Information
  • Founded
  • VRAR 2016
  • IBIO 2008
  • Country
  • VRAR United States
  • IBIO United States
  • Employees
  • VRAR N/A
  • IBIO N/A
  • Industry
  • VRAR Retail: Computer Software & Peripheral Equipment
  • IBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRAR Technology
  • IBIO Health Care
  • Exchange
  • VRAR Nasdaq
  • IBIO Nasdaq
  • Market Cap
  • VRAR N/A
  • IBIO 24.3M
  • IPO Year
  • VRAR 2021
  • IBIO N/A
  • Fundamental
  • Price
  • VRAR $1.14
  • IBIO $0.92
  • Analyst Decision
  • VRAR Strong Buy
  • IBIO Strong Buy
  • Analyst Count
  • VRAR 1
  • IBIO 3
  • Target Price
  • VRAR $2.62
  • IBIO $4.87
  • AVG Volume (30 Days)
  • VRAR 114.4K
  • IBIO 1.2M
  • Earning Date
  • VRAR 05-14-2025
  • IBIO 05-12-2025
  • Dividend Yield
  • VRAR N/A
  • IBIO N/A
  • EPS Growth
  • VRAR N/A
  • IBIO N/A
  • EPS
  • VRAR 0.86
  • IBIO N/A
  • Revenue
  • VRAR $591,251,000.00
  • IBIO $375,000.00
  • Revenue This Year
  • VRAR N/A
  • IBIO $36.00
  • Revenue Next Year
  • VRAR $30.52
  • IBIO $33.33
  • P/E Ratio
  • VRAR N/A
  • IBIO N/A
  • Revenue Growth
  • VRAR N/A
  • IBIO 650.00
  • 52 Week Low
  • VRAR $0.50
  • IBIO $0.87
  • 52 Week High
  • VRAR $7.00
  • IBIO $6.89
  • Technical
  • Relative Strength Index (RSI)
  • VRAR 49.15
  • IBIO 23.93
  • Support Level
  • VRAR $0.97
  • IBIO $0.64
  • Resistance Level
  • VRAR $1.08
  • IBIO $1.00
  • Average True Range (ATR)
  • VRAR 0.09
  • IBIO 0.27
  • MACD
  • VRAR 0.03
  • IBIO -0.01
  • Stochastic Oscillator
  • VRAR 69.23
  • IBIO 11.82

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: